CIPLA LTD. (INDIA)

Soranib

“Soranib” contains the Drug / Molecule called “Sorafenib”. Sorafenib is a small molecular inhibitor of several tyrosine protein kinases. Soranib treatment induces catabolic mechanism that involve cell degradation; which may suppress tumor growth.

Details
Specification

Indication

Soranib is used for the treatment of Primary Kidney Cancer (Advanced Renal Cell Carcinoma) and Advanced Primary Liver Cancer.

DOSAGE AND ADMINISTRATION:

Recommended daily dose is 400 mg (2 X 200 mg tablets) taken twice daily without food (at least 1 hour before or 2 hours after a meal).

Note

SIDE EFFECT :

Most commonly occurring Cardiac Ischemia, infarction, Hemorrhage, Hypertension, Hand-Foot skin reaction and rash, Gastrointestinal perforation, Wound healing complications.

INTERACTIONS :

Interaction with Docetaxel & Doxorubicin : Soranib can cause increase in plasma concentration of Docetaxel & Doxorubicin

OVERDOSE :

There is no specific treatment for Soranib overdose. In cases of suspected overdose soranib should be withheld and supportive care instituted.

Precaution

Soranib is a prescription drug and should be used under proper medical guidance and advice.
Caution has to be taken in case of kidney / liver problems, pregnancy and lactation.

Updated On Oct 15, 2019 by Admin

Strength

200 mg

Packing

1 X 30 Tablets (Plastic Container) & 1 X 120 Tablets (Plastic Container)

Storage

Store in a cool place, protect from light.

Was this page helpful?

☆ ☆ ☆ ☆ ☆

Not Upto Date Insufficient Helpful

Any suggestions or inputs for Shubhampharma.

Soranib also available as

Bayer

Nexavar-soranib

"Nexavar" contains the Drug / Molecule called “Sorafenib”. Sorafenib is a small molecular inhibitor of several tyrosine protein kinases. Nexavar treatment induces catabolic mechanism that involve cell degradation; which may suppress tumor growth.

“Soranib” is the generic version of “Nexavar” and both contains same drug “Sorafenib”.